417 results on '"Fuchs, Bryan C."'
Search Results
2. Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice
3. Molecular MR Imaging of Renal Fibrogenesis in Mice
4. Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver
5. An angiotensin system inhibitor (Losartan) potentiates anti-tumor efficacy of cisplatin in a murine model of non-small cell lung cancer
6. A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis
7. Prevention Strategies for Hepatocellular Carcinoma
8. Precision-Cut Liver Slices as anex vivomodel to evaluate antifibrotic therapies for liver fibrosis and cirrhosis
9. Collagen-targeted molecular imaging in diffuse liver diseases
10. A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery
11. Author Correction: Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
12. Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
13. Molecular Magnetic Resonance Imaging of Liver Fibrosis and Fibrogenesis Is Not Altered by Inflammation
14. Cell type-specific pharmacological kinase inhibition for cancer chemoprevention
15. Molecular imaging of fibrosis: recent advances and future directions
16. Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis
17. pH dependence of a GPR4 selective antagonist hampers its therapeutic potential
18. Author Correction: Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis
19. Molecular Magnetic Resonance Imaging of Fibrin Deposition in the Liver as an Indicator of Tissue Injury and Inflammation
20. Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A
21. Figure from Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI
22. Supplementary Legends, Table from Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI
23. Human Fecal Bile Acid Analysis after Investigational Microbiota-Based Live Biotherapeutic Delivery for Recurrent Clostridioides difficile Infection
24. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma
25. 3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model
26. A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity
27. HUMAN FECAL BILE ACID ANALYSIS AFTER INVESTIGATIONAL MICROBIOTA-BASED LIVE BIOTHERAPEUTIC DELIVERY FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION
28. Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram
29. Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation
30. Peroxidasin deficiency re-programs macrophages toward pro-fibrolysis function and promotes collagen resolution in liver
31. Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis
32. Abstract 255: Peroxidasin deficiency recruits pro-healing macrophages into the liver and inhibits NAFLD progression to HCC
33. Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
34. Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model
35. Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions
36. Epithelial to Mesenchymal Transition is Associated with Shorter Disease-Free Survival in Hepatocellular Carcinoma
37. Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells
38. Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells
39. Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance
40. Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis
41. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study
42. Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition
43. CD44 Single Nucleotide Polymorphism and Isoform Switching May Predict Gastric Cancer Recurrence
44. Reply
45. Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram.
46. Quantitative molecular magnetic resonance imaging (MRI) of lysyl oxidase-mediated collagen crosslinking during liver fibrosis: 17
47. Molecular MR imaging of Collagen Accurately Monitors Reduced Biliary Fibrosis Progression in Response to Rapamycin: 18
48. Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer
49. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
50. A Blood-Based Prognostic Liver Secretome Signature and Long-Term Hepatocellular Carcinoma Risk in Advanced Liver Fibrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.